{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:33:34Z","timestamp":1778232814183,"version":"3.51.4"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.bpg.2007.11.001","type":"journal-article","created":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T07:52:36Z","timestamp":1205653956000},"page":"279-294","source":"Crossref","is-referenced-by-count":19,"title":["Acute variceal bleeding: Pharmacological treatment and primary\/secondary prophylaxis"],"prefix":"10.1016","volume":"22","author":[{"given":"A.","family":"Dell'Era","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"de Franchis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2007.11.001_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep.510250145","article-title":"Hepatic venous pressure measurement: an old test as new prognostic marker in cirrhosis?","volume":"25","author":"Armonis","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0168-8278(91)90088-S","article-title":"Can we predict the first variceal bleeding in the individual patient with cirrhosis and esophageal varices","volume":"13","author":"Merkel","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients","volume":"346","author":"Levacher","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2007.11.001_bib4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(97)05099-X","article-title":"Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial","volume":"350","author":"Avgerinos","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2007.11.001_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/jhep.2002.31354","article-title":"Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis","volume":"35","author":"Ba\u00f1ares","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis","year":"2005","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0168-8278(03)00322-2","article-title":"Cirrhosis and bleeding: the need for very early management","volume":"39","author":"Nidegger","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.1840110423","article-title":"A randomized trial of terlipressin plus nitroglycerin vs ballon tamponade in the control of acute variceal haemorrhage","volume":"11","author":"Fort","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/jhep.2002.33469","article-title":"Somatostatin and analogues in portal hypertension","volume":"35","author":"Abraldes","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach","volume":"19","author":"D'Amico","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2007.11.001_bib11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.1840220145","article-title":"The treatment of portal hypertension: a meta-analytic review","volume":"22","author":"D'Amico","year":"1995","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bpg.2007.11.001_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.1840100612","article-title":"Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial","volume":"10","author":"Bosch","year":"1989","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.bpg.2007.11.001_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(85)80770-4","article-title":"Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators","volume":"1","author":"Bathal","year":"1985","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/003655298750027100","article-title":"Development of analogues: successes and failures","volume":"226","author":"Bosch","year":"1998","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"3","key":"10.1016\/j.bpg.2007.11.001_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/jhep.2000.16601","article-title":"Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study","volume":"32","author":"Escorsell","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib17","first-page":"CD002147","article-title":"Terlipressin for acute esophageal variceal hemorrhage (Cochrane Review)","volume":"1","author":"Ioannou","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpg.2007.11.001_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1053\/gast.1996.v111.pm8898643","article-title":"Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group","volume":"111","author":"Feu","year":"1996","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2007.11.001_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profile of the haemodynamic effects of terlipressin in portal hypertension","volume":"26","author":"Escorsell","year":"1997","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2036.2003.01356.x","article-title":"Systematic review: terlipressin in acute oesophageal variceal haemorrhage","volume":"17","author":"Ioannou","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/emj.2006.035147","article-title":"Best evidence topic report. Terlipressin or sclerotherapy for acute variceal bleeding?","volume":"23","author":"McAuley","year":"2006","journal-title":"Emergency Medicine Journal"},{"key":"10.1016\/j.bpg.2007.11.001_bib23","first-page":"106","article-title":"Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation","volume":"22","author":"Cirera","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(81)90014-7","article-title":"Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin","volume":"80","author":"Bosch","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0168-8278(98)80259-6","article-title":"Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group","volume":"29","author":"Escorsell","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0168-8278(01)00206-9","article-title":"Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding","volume":"35","author":"Moitinho","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/gast.2001.20892","article-title":"Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension","volume":"120","author":"Escorsell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/gast.2001.22451","article-title":"Octreotide for acute esophageal variceal bleeding: a meta-analysis","volume":"120","author":"Corley","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib29","first-page":"352A","article-title":"Double blind RCT of 5day octreotide versus placebo, associated with sclerotherapy for trial failures","volume":"24","author":"Burroughs","year":"1996","journal-title":"Hepatology"},{"issue":"73","key":"10.1016\/j.bpg.2007.11.001_bib30","first-page":"195","article-title":"Octreotide for esophageal variceal bleeding treated with endoscopic sclerotheraphy: a randomized, placebo \u2013 controlled trial","volume":"54","author":"Morales","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"2\u20133","key":"10.1016\/j.bpg.2007.11.001_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000180979","article-title":"Effects of somatostatin in patients with portal hypertension","volume":"29","author":"Bosch","year":"1988","journal-title":"Horm Res"},{"key":"10.1016\/j.bpg.2007.11.001_bib32","first-page":"CD002907","article-title":"Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding","volume":"2","author":"Soares-Weiser","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.bpg.2007.11.001_bib33","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0002-9270(99)00349-4","article-title":"Risk factors for the development of bacterial infections in hospitalised patients with cirrhosis","volume":"94","author":"Deschenes","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.bpg.2007.11.001_bib34","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","article-title":"Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis","volume":"29","author":"Bernard","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2007.11.001_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","article-title":"Norfloxacin versus ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage","volume":"131","author":"Fernandez","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hep.1840180514","article-title":"Randomized controlled trial of desmopressin plus terlipressin versus terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club","volume":"18","author":"de Franchis","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2007.11.001_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-3148.1993.tb00046.x","article-title":"Impact of aprotinin on blood transfusion requirements in liver transplantation","volume":"3","author":"Smith","year":"1993","journal-title":"Transfus Med"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2004.07.015","article-title":"Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomised, double-blind trial","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.bpg.2007.11.001_bib40","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1016\/S0168-8278(07)62383-6","article-title":"Recombinant factor VIIa (RFVIIA) for active variceal bleeding in patients with advanced cirrhosis: a multi-centre randomized double-blind placebo-controlled trial","volume":"46","author":"Bosch","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the 1st variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices \u2013 a prospective multicenter study","volume":"319","author":"North Italian Endoscopic Club","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0168-8278(92)90044-P","article-title":"Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy","volume":"15","author":"de Franchis","year":"1992","journal-title":"J Hepatol"},{"issue":"8226","key":"10.1016\/j.bpg.2007.11.001_bib43","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0140-6736(81)91617-2","article-title":"Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients","volume":"1","author":"Lebrec","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hep.1840020502","article-title":"The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study","volume":"2","author":"Lebrec","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.510250112","article-title":"Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis","volume":"25","author":"Bernard","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib46","series-title":"Portal Hypertension III, Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies","first-page":"180","article-title":"Complications of the medical treatment of portal hypertension","author":"Bolognesi","year":"2001"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","article-title":"Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension","volume":"33","author":"de Franchis","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","article-title":"Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis","volume":"346","author":"Feu","year":"1995","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib49","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib50","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hep.1840130517","article-title":"Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group","volume":"13","author":"Conn","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib51","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/jhep.2001.29305","article-title":"Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?","volume":"34","author":"Abraczinskas","year":"2001","journal-title":"Hepatology"},{"issue":"8187","key":"10.1016\/j.bpg.2007.11.001_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(80)90063-X","article-title":"Propranolol\u2014a medical treatment for portal hypertension?","volume":"2","author":"Lebrec","year":"1980","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.bpg.2007.11.001_bib53","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","volume":"324","author":"Poynard","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bpg.2007.11.001_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-117-1-59","article-title":"Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment","volume":"117","author":"Pagliaro","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib55","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib56","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198112033052302","article-title":"Propranolol for prevention of recurrent gastrointestinal bleeidng in patients with cirrhosis","volume":"305","author":"Lebrec","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM198312223092502","article-title":"Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis","volume":"25","author":"Burroughs","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib58","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.1840060602","article-title":"Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial","volume":"6","author":"Villeneuve","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hep.1840090315","article-title":"Beta-blockade prevents recurrent gastrointestinal bleeding in well compensated patients with alcoholic cirrhosis: a multicenter randomised controlled trial","volume":"9","author":"Colombo","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib60","first-page":"851","article-title":"Propranolol in the prevention of variceal haemorrhage in alcoholic cirrhotic patients (abstract)","volume":"12","author":"Colman","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0016-5085(90)91308-S","article-title":"Propranolol in the prevention of recurrent variceal haemorrhage in cirrhotic patients","volume":"98","author":"Garden","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0168-8278(91)90828-Y","article-title":"Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy","volume":"12","author":"Rossi","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib63","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0168-8278(97)80047-5","article-title":"Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis. A meta-analysis","volume":"26","author":"Bernard","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2007-1007130","article-title":"Influence of pharmacological agents on portal hemodynamics: Basis for its use in the treatment of portal hypertension","volume":"19","author":"Garcia-Pagan","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2007.11.001_bib65","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0016-5085(01)81028-3","article-title":"Isosorbide mononitrate in the prevention of first bleed in patients who cannot receive beta-blockers","volume":"121","author":"Garcia Pagan","year":"2001","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib66","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1053\/gast.1997.v113.agast971131794","article-title":"Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly","volume":"113","author":"Groszmann","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib67","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1053\/gast.1997.v113.pm9352866","article-title":"Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis","volume":"113","author":"Angelico","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2007.11.001_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0168-8278(02)00174-5","article-title":"Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites","volume":"37","author":"Borroni","year":"2002","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2007.11.001_bib69","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/gast.2002.35385","article-title":"Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate","volume":"123","author":"Lui","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2007.11.001_bib70","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.1840200620","article-title":"Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects","volume":"20","author":"Morillas","year":"1994","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib71","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0016-5085(95)90586-3","article-title":"Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function","volume":"109","author":"Albillos","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2007.11.001_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(98)70372-5","article-title":"Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension","volume":"115","author":"Albillos","year":"1998","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2007.11.001_bib73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-114-10-869","article-title":"Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study","volume":"114","author":"Garcia-Pagan","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib74","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(96)05406-2","article-title":"Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)","volume":"348","author":"Merkel","year":"1996","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.bpg.2007.11.001_bib75","article-title":"Isosorbide mononitrate (IMN) with nadolol compared to nadolol alone for prevention of first bleeding in cirrhosis: a double blind placebo-controlled randomised trial","volume":"30","author":"Pietrosi","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib76","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/jhep.2003.50211","article-title":"Propranolol+placebo versus Propranolol+isosorbide-5-mononitrate in the prevention of the first variceal bleed. A double blind RCT","volume":"37","author":"Garcia-Pagan","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib77","series-title":"Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies","first-page":"127","article-title":"Primary prophylaxis","author":"Garcia-Pagan","year":"2001"},{"issue":"6","key":"10.1016\/j.bpg.2007.11.001_bib78","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/jhep.2000.8106","article-title":"Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding","volume":"31","author":"Gournay","year":"2000","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.bpg.2007.11.001_bib79","article-title":"Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double blind placebo-controlled randomised trial. Final report","volume":"34","author":"Patti","year":"2001","journal-title":"J Hepatol"},{"issue":"25","key":"10.1016\/j.bpg.2007.11.001_bib80","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199606203342502","article-title":"Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding","volume":"334","author":"Villanueva","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib81","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa003223","article-title":"Endoscopic ligation compared with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding","volume":"345","author":"Villanueva","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.11.001_bib82","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/gast.2002.35351","article-title":"Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding","volume":"123","author":"Lo","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib83","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/gast.2002.35955","article-title":"A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis","volume":"123","author":"Patch","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2007.11.001_bib84","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2036.2006.03007.x","article-title":"Comparative study between nadolol and 5-isosorbide mononitrate versus endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial","volume":"24","author":"Romero","year":"2006","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1016\/j.bpg.2007.11.001_bib85","series-title":"Treatments in Hepatology","first-page":"25","article-title":"TIPS in the prevention of variceal rebleeding. Results of randomized controlled trials","author":"Escorsell","year":"1999"},{"key":"10.1016\/j.bpg.2007.11.001_bib86","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/jhep.2002.36947","article-title":"Randomised comparison of long term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Ba\u00f1ares","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2007.11.001_bib87","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hep.1840190506","article-title":"Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis","volume":"19","author":"Garcia-Pagan","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/jhep.2003.50032","article-title":"Nadolol plus spironalctone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: a preliminary study","volume":"37","author":"Abecasis","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2007.11.001_bib89","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.510290203","article-title":"Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis","volume":"29","author":"Schneider","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2007.11.001_bib90","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/gast.2001.26288","article-title":"Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis","volume":"121","author":"Gonzalez-Abraldes","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/gast.2001.26295","article-title":"Haemodynamic effect of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension","volume":"121","author":"Schepke","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.11.001_bib92","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0168-8278(02)00443-9","article-title":"Effects of long term irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study","volume":"38","author":"De Bernardi Venon","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2007.11.001_bib93","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2003.07497.x","article-title":"Portal pressure response to losartan compared with propranolol in patients with cirrhosis","volume":"98","author":"De","year":"2003","journal-title":"Am J Gastroenterol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691807001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691807001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:25:06Z","timestamp":1557361506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691807001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1521691807001345"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2007.11.001","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}